Aditxt Inc (ADTX)
1.94
-0.01
(-0.51%)
USD |
NASDAQ |
May 31, 16:00
1.92
-0.02
(-1.03%)
After-Hours: 20:00
Aditxt Enterprise Value: 9.286M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 9.286M |
| May 30, 2024 | 9.303M |
| May 29, 2024 | 9.370M |
| May 28, 2024 | 9.403M |
| May 24, 2024 | 9.436M |
| May 23, 2024 | 9.503M |
| May 22, 2024 | 9.569M |
| May 21, 2024 | 9.519M |
| May 20, 2024 | 9.536M |
| May 17, 2024 | 9.403M |
| May 16, 2024 | 9.403M |
| May 15, 2024 | 9.470M |
| May 14, 2024 | 9.719M |
| May 13, 2024 | 9.486M |
| May 10, 2024 | 9.503M |
| May 09, 2024 | 9.503M |
| May 08, 2024 | 9.553M |
| May 07, 2024 | 9.453M |
| May 06, 2024 | 9.653M |
| May 03, 2024 | 9.886M |
| May 02, 2024 | 10.17M |
| May 01, 2024 | 10.07M |
| April 30, 2024 | 10.07M |
| April 29, 2024 | 10.07M |
| April 26, 2024 | 10.04M |
| Date | Value |
|---|---|
| April 25, 2024 | 10.27M |
| April 24, 2024 | 10.00M |
| April 23, 2024 | 9.836M |
| April 22, 2024 | 9.752M |
| April 19, 2024 | 9.969M |
| April 18, 2024 | 10.07M |
| April 17, 2024 | 9.969M |
| April 16, 2024 | 10.10M |
| April 15, 2024 | 10.50M |
| April 12, 2024 | 11.07M |
| April 11, 2024 | 11.30M |
| April 10, 2024 | 11.25M |
| April 09, 2024 | 11.55M |
| April 08, 2024 | 11.23M |
| April 05, 2024 | 11.23M |
| April 04, 2024 | 11.45M |
| April 03, 2024 | 11.20M |
| April 02, 2024 | 11.67M |
| April 01, 2024 | 11.35M |
| March 31, 2024 | 11.72M |
| March 28, 2024 | 21.73M |
| March 27, 2024 | 21.13M |
| March 26, 2024 | 21.24M |
| March 25, 2024 | 21.36M |
| March 22, 2024 | 21.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.536M
Minimum
Dec 28 2022
63.73M
Maximum
Feb 11 2021
15.43M
Average
10.93M
Median
Dec 17 2020
Enterprise Value Benchmarks
| Evofem Biosciences Inc | 43.23M |
| Perspective Therapeutics Inc | 680.29M |
| Electromed Inc | 114.83M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.73M |
| Revenue (Quarterly) | 0.0797M |
| Total Expenses (Quarterly) | 11.62M |
| EPS Diluted (Quarterly) | -9.14 |
| Gross Profit Margin (Quarterly) | 17.42% |
| Profit Margin (Quarterly) | -18.49K% |
| Earnings Yield | -5.32K% |
| Normalized Earnings Yield | -5309.91 |